HomeCompareAPRAF vs BTI

APRAF vs BTI: Dividend Comparison 2026

APRAF yields 699.30% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 APRAF wins by $901150.64M in total portfolio value
10 years
APRAF
APRAF
● Live price
699.30%
Share price
$0.29
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$901150.68M
Annual income
$703,308,220,475.50
Full APRAF calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — APRAF vs BTI

📍 APRAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPRAFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APRAF + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
APRAF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APRAF
Annual income on $10K today (after 15% tax)
$59,440.56/yr
After 10yr DRIP, annual income (after tax)
$597,811,987,404.17/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, APRAF beats the other by $597,811,985,022.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APRAF + BTI for your $10,000?

APRAF: 50%BTI: 50%
100% BTI50/50100% APRAF
Portfolio after 10yr
$450575.36M
Annual income
$351,654,111,638.89/yr
Blended yield
78.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

APRAF
No analyst data
Altman Z
19.6
Piotroski
0/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APRAF buys
0
BTI buys
0
No recent congressional trades found for APRAF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPRAFBTI
Forward yield699.30%5.40%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$901150.68M$37.8K
Annual income after 10y$703,308,220,475.50$2,802.29
Total dividends collected$885128.61M$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: APRAF vs BTI ($10,000, DRIP)

YearAPRAF PortfolioAPRAF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$80,630$69,930.07$11,301$601.08+$69.3KAPRAF
2$613,234$526,959.48$12,799$706.58+$600.4KAPRAF
3$4,401,769$3,745,608.55$14,527$832.38+$4.39MAPRAF
4$29,836,846$25,126,953.37$16,527$982.75+$29.82MAPRAF
5$191,102,955$159,177,529.74$18,846$1,162.95+$191.08MAPRAF
6$1,157,303,697$952,823,535.23$21,545$1,379.49+$1157.28MAPRAF
7$6,631,044,458$5,392,729,502.87$24,694$1,640.41+$6631.02MAPRAF
8$35,972,708,654$28,877,491,083.07$28,378$1,955.69+$35972.68MAPRAF
9$184,899,497,226$146,408,698,966.59$32,702$2,337.79+$184899.46MAPRAF
10$901,150,682,507$703,308,220,475.50$37,794$2,802.29+$901150.64MAPRAF

APRAF vs BTI: Complete Analysis 2026

APRAFStock

Trailbreaker Resources Ltd. operates as a mineral exploration company in Canada. The company primarily explores for gold. Its flagship property is Plateau property that comprises 3,167 contiguous quartz claims covering 662 square kilometers located in Yukon Territory. The company's projects also include Atsutla gold project consisting of 28 mineral tenures and covering an area of approximately 37,000 hectares located in northwestern British Columbia; the Skelly property covering an area of 2,525.59 hectares located in south of the British Columbia-Yukon border; and McMurdo property covering an area of 1727.62 hectares located in southeastern British Columbia. In addition, it holds a 100% interest in the Eakin Creek property that covers an area of 1,610 hectares located in South-Central British Columbia; a 100% interest in the Connector Gold property covering an area of 1,894 hectares located in the Merritt area of British Columbia; and a 100% interest in the Eagle Lake property that covers an area of 18,990 hectares located in south-central British Columbia. The company was formerly known as Goldstrike Resources Ltd. and changed its name to Trailbreaker Resources Ltd. in March 2021. Trailbreaker Resources Ltd. was incorporated in 1989 and is based in Vancouver, Canada.

Full APRAF Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this APRAF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APRAF vs SCHDAPRAF vs JEPIAPRAF vs OAPRAF vs KOAPRAF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.